TY - JOUR
T1 - Pregnancy and Congenital Heart Disease
T2 - A Brief Review of Risk Assessment and Management
AU - Chan, Alice
AU - Wolfe, Diana S.
AU - Zaidi, Ali L.I.N.
N1 - Publisher Copyright:
© 2020Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Cardiac disease is a leading cause of morbidity and mortality in pregnant women. An increased prevalence of the cardiovascular disease has been found in women of childbearing age, in which the responsibility of the treating physician extends to the mother and to the unborn fetus. As a result, care of these high-risk pregnant women with cardiovascular disease including those with congenital heart disease (CHD) require a team approach including specialists in maternal-fetal medicine, adult congenital cardiology, and obstetrical anesthesia. The human body undergoes significant amounts of physiological changes during this period of time and the underlying cardiac disease can affect both the mother and the fetus. Today, most female children born with CHD will reach childbearing age. For many women with complex CHD, carrying a pregnancy has a moderate to high risk for both the mother and her fetus. This chapter will review the epidemiology, risk factors, clinical presentation including common signs and symptoms, physiological changes in pregnancy, and the medical approach including cardiac medications, percutaneous interventions, and surgical procedures for pregnant women with CHD.
AB - Cardiac disease is a leading cause of morbidity and mortality in pregnant women. An increased prevalence of the cardiovascular disease has been found in women of childbearing age, in which the responsibility of the treating physician extends to the mother and to the unborn fetus. As a result, care of these high-risk pregnant women with cardiovascular disease including those with congenital heart disease (CHD) require a team approach including specialists in maternal-fetal medicine, adult congenital cardiology, and obstetrical anesthesia. The human body undergoes significant amounts of physiological changes during this period of time and the underlying cardiac disease can affect both the mother and the fetus. Today, most female children born with CHD will reach childbearing age. For many women with complex CHD, carrying a pregnancy has a moderate to high risk for both the mother and her fetus. This chapter will review the epidemiology, risk factors, clinical presentation including common signs and symptoms, physiological changes in pregnancy, and the medical approach including cardiac medications, percutaneous interventions, and surgical procedures for pregnant women with CHD.
KW - anticoagulation in pregnancy
KW - cardiac disease
KW - cardiomyopathy
KW - cardiovascular disease
KW - congenital heart disease
KW - heart failure
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85095461016&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095461016&partnerID=8YFLogxK
U2 - 10.1097/GRF.0000000000000579
DO - 10.1097/GRF.0000000000000579
M3 - Review article
C2 - 33074980
AN - SCOPUS:85095461016
SN - 0009-9201
VL - 63
SP - 836
EP - 851
JO - Clinical obstetrics and gynecology
JF - Clinical obstetrics and gynecology
IS - 4
ER -